Articles

Drugs approved with companion diagnostic tests represent the next wave of personalized medicine and have the potential to significantly improve patient outcomes.

Industrial & Environmental — Develops biotechnology industry policy on environmental and industrial biotechnology issues, promotes the use of industrial enzymes, conversion of biomass to energy and chemicals, and innovative clean up technologies.

BIO has long supported responsible and ethical testing, protection of individual privacy and genetic information, and regulatory systems that best serve humanity and advance research into new treatments for patients, regardless of where research is conducted.

BIO Asia will be held January 31 – February 1, 2012 in Osaka, Japan.

The challenge of conversion of biomass – particularly lignocellulosic biomass and agricultural waste – into chemicals, materials and fuels is being approached in multiple directions and a slew of technologies are now being developed, tested and deployed in semicommercial or pilot stage.

The timing for building a biobased economy as an option to the current petroleum-based one, to provide fuels, chemicals, materials and energy sustainably for the long term future cannot be better.

Harnessing microbes to change the world, one process at a time.

Biotechnology continues to hold the greatest promise to address many of the most critical issues facing our world.

What does the future hold for the biotechnology industry in Japan? The Japanese government has made great strides to boost biotech within its borders.

Pavilions attract attendees and media alike, affording a space to tell your story within the context of a particular geographic region or specific focus area.

New Orleans shows the signs of a city reborn from the destruction brought on by Hurricane Katrina.  The changes in the city’s infrastructure and building projects have certainly been among them.  The city reached a  milestone its renaissance when the New Orleans BioInnovation Center (NOBIC) opened for business.

It’s time for us to embrace science, educate ourselves on its benefits, and encourage – not impede – forward thinking. Our future might depend on it!

BioMalaysia 2011 and 2011 Pacific Rim Summit on Industrial Biotechnology and Bioenergy were held jointly in Kuala Lumpur Nov. 21-23.

Congress has the opportunity to help speed lifesaving cures and treatments to patients by removing burdens to innovation in our industry.

Jobs and salaries in this industry have substantially grown in the past ten years. To date, there are more than 47,000 bioscience companies and 1.4 million workers in the United States.

In this informative editorial Jim Greenwood, BIO President and CEO, presents an insight into China’s growing role in the future of biotechnology.

The Therapeutic Discovery Project provided much-needed relief for emerging biotech companies  working on life-saving treatments and cures

With the overwhelming success of our recent Call for Sessions, next year’s BIO International Convention may be the best yet!

The Small Business Innovation Research Grants Program Provides Critical Support to Small Biotech Companies Working on Promising Innovations

BIO President and CEO Jim Greenwood congratulated the FDA and biopharmaceutical sponsors for making 35 novel new treatments available to patients in FY11.

Underlying the PDUFA V recommendations are the principles that a science-based, transparent, and well-managed review process that appropriately balances benefits and risks can enhance public trust and increase patient access to new medicines.

Genetic engineering is the direct manipulation of an organism's genes. Genetic engineering is different from traditional breeding, where the organism's genes are manipulated indirectly.

While the U.S. leads in the area of biotechnology, there is no guarantee this competitive edge will continue.

Where can you network and partner with 15,000+ industry leaders from 65 countries across the globe?